-5.0%
MRNA vs CPB
-33.2%
+28.2%
-93.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | CPB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +3.2% | -6.6% | -4.3% |
| 7D | -12.1% | -1.6% | -10.6% | -11.8% |
| 30D | -1.3% | +19.2% | -20.5% | -6.0% |
| 3M | +250.9% | -0.9% | +251.9% | +252.9% |
| 6M | +343.0% | +15.2% | +327.8% | +338.7% |
| YTD | +657.4% | -13.1% | +670.5% | +672.8% |
| 1Y | +794.9% | -22.4% | +817.3% | +835.0% |
| 3Y | +218.1% | -35.3% | +253.4% | +237.4% |
| All | -5.0% | -33.2% | +28.2% | +10.0% |
Cumulative growth
Daily Returns
Daily percentage return beside CPB.
Daily Out/Under-Performance
Portfolio return minus CPB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CPB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded CPB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling